Skip to main content
. 2021 Nov 16;12:6612. doi: 10.1038/s41467-021-26884-7

Table 1.

SARS-CoV-2 genome single nucleotide variants (SNVs) in postmortem tissues and plasma of case 13.

Genea Nt change AA change Frequency of detection per anatomical compartment (%)b
Lungs Plasma Heart Kidney Liver Spleen
ORF1a T322A / 40,81 0 6,57 0 0 0
ORF1a G1068A NSP2:G268E 0 0 0 0 0 28,5
ORF1a C1862T NSP2:L533F 33,28 5,9 8,78 0 0 3,11
ORF1a C2094T NSP2:S610L 99,56 99,55 99,62 100 100 99,62
ORF1a T2149C / 20,58 1,35 <1 <1 <1 <1
ORF1a T5395A NSP3:F2328V 39,67 5,95 4,12 <1 11,9 4,03
ORF1a A5405G NSP3:I1714V 17,73 10,45 30,22 5,76 10,89 4,1
ORF1a T5406C NSP3:I1714T 10,63 12,5 28,95 89,21 32,82 6,63
ORF1a C7239T NSP3:A2325V 46,19 8,06 20,07 <1 16,67 5,56
ORF1a T7247G NSP3:F2328V 29,24 14,66 6,78 87,36 37,5 6,77
ORF1a C7279T / 1,17 1,84 <1 83,3 <1 <1
ORF1a C8175T NSP3:A2637V 14,31 45,94 42,28 1,85 38,91 11,11
ORF1a A8387G NSP3:N2708D 1,92 2,89 <1 88,86 2,5 1,32
ORF1a C9438T NSP4:T3058I 14,4 44,24 24,27 1,11 35,56 11,64
ORF1a C9491T NSP4:H3076Y 2,84 1,28 33,29 <1 5,65 4,05
ORF1a A9737G NSP4:S3158G 39,58 9,44 7,07 44,79 13,87 5,96
ORF1a C10369T / 1,54 <1 <1 <1 6,04 27,3
ORF1a C11008T / 20,69 2,92 5,3 <1 3,69 2,17
ORF1a C12439T NSP8:P4058L 8,71 5,35 5,76 48,05 21,86 4,07
ORF1a C12513T NSP8:T4083M <1 <1 <1 7,04 <1 62,73
ORF1a T13417C / 99,25 98,09 97,72 99,15 94,8 98,89
ORF1a A13433G NSP10:M4390G 1,13 1,59 <1 30,19 1,84 <1
ORF1b A13947T / 99,5 99,17 99,46 99,26 99,64 98,96
ORF1b C14786T RdRp:A440V 46,74 4,66 8,13 <1 8,85 3,66
ORF1b C14937T / <1 <1 <1 <1 <1 64,31
ORF1b C15222T / 1,84 24,59 7,67 1,24 7,97 2,96
ORF1b C16092T / <1 <1 <1 30,42 <1 <1
ORF1b C17004T / 39 6,46 13,84 0 7,85 4,12
ORF1b T18024C / <1 <1 <1 27,86 <1 <1
ORF1b A18179G NSP14:K1571R <1 27,26 4,86 <1 6,34 3,35
ORF1b T18678C / <1 30,76 6,55 <1 7,03 3,55
ORF1b T18750C / <1 <1 <1 27,13 <1 <1
ORF1b C18979T NSP14:H1838Y <1 <1 <1 40,81 <1 <1
S C21789T S:T76I 41,05 7,19 <1 <1 11,52 4,13
S G22363T / 4,65 2,14 <1 43,97 3,4 1,06
S G22661T S:V367F 5,62 <1 10,34 3,07 1,9 68,08
S A22920T S:Y453F 52,52 <1 <1 <1 11,13 5,06
S A23063T S:N501Y 18,46 14,29 20,69 39,63 31,27 5,04
S G23782A S:M740I 20,87 8,26 <1 <1 4,55 1,72
S G24316T S:E918D <1 3 45,65 <1 11,33 1,94
S T24450C S:V963A 36,09 6,21 16,15 <1 11,27 3,15
S C24642T S:T1027I 44,18 27,94 27,48 49,78 23,26 7,74
E C26333T E:T30I 83,41 49,57 81,39 2,25 60,29 41,17
E C26351T E:A36V <1 <1 <1 <1 <1 33,61
ORF7a A27574T ORF7a:T61S 2 2,1 <1 88,65 3,16 <1
N A28336T / <1 <1 <1 <1 <1 62,93
N C29200T / <1 <1 54,51 <1 <1 <1
N A29424G N:Q384R  < 1 <1 <1 27,03 <1 <1
ORF10 C29592T ORF10:T34M 1,78 1,45 1,98 49,64 2,76 <1
3’ UTR G29744A / <1 <1 <1 <1 <1 61,12

Variants were mapped to clade 20B genome and called if case frequencies were higher than 20% in at least one anatomical compartment. SNV frequency is noted per organ.

aGene names are italicized in the table.

bBold numbers indicate that the latter variant was also identified in SARS-CoV-2 progeny on Vero E6 cells of respective tissue samples (frequencies >1%).